Talk:Fenofibrate

From Citizendium
Revision as of 22:55, 27 May 2008 by imported>Howard C. Berkowitz (→‎Synergistic use of PPARs for different subreceptors?: new section)
Jump to navigation Jump to search
This article is a stub and thus not approved.
 Main Article
 Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
To learn how to update the categories for this article, see here. To update categories, edit the metadata template.
 Definition:  Antilipemic medication which reduces both cholesterol and triglycerides in the blood. [d] [e]
Checklist and Archives
 Workgroup categories:  Health Sciences and Chemistry [Categories OK]
 Subgroup category:  Biochemistry
 Talk Archive:  none  English language variant:  American English

Synergistic use of PPARs for different subreceptors?

Both for personal use and research interest, I've been following some of the literature in the combined use of thiazolidinediones and fibrates. As you probably know, there seem to be some synergies in lowering cardiovascular risk, perhaps also with the fibrate potentiating the TZD role in decreasing insulin resistance by lowering circulating FFA.

Where might such a discussion go?

Howard Howard C. Berkowitz 23:55, 27 May 2008 (CDT)

Retrieved from "https://citizendium.org/wiki/index.php?title=Talk:Fenofibrate&oldid=393328"